India-UK FTA Pharma Exports: $1B Target Achievable in 5-7 Years, Regulatory Hurdles Key

With tariffs already near zero, the real prize lies in GMP mutual recognition and faster registration pathways—but IP concessions on data exclusivity could erode gains for Indian generics makers.

bt-corporate · 7/17/2026, 9:31:27 AM · Ask about this →